logo-loader
viewMoneysupermarket.com

Moneysupermarket.com extends last week’s post-results decline as Citigroup downgrades to ‘neutral’ from ‘buy’

The US bank also chopped its target price for the FTSE 250-listed firm back to 300p from 400p after reducing estimates, with the shares trading at 270.70p, down 1.9%

Shares downgrade
Citi's analysts said they "prefer to wait on the sidelines until a clearer path to stronger profit growth emerges”

Moneysupermarket.com PLC (LON:MONY) extended last week’s post-results decline on Tuesday as Citigroup downgraded its stance on the price comparison website group to ‘neutral’ from ‘buy’.

The US bank also chopped its target price for the FTSE 250-listed firm back to 300p from 400p after reducing estimates, with the shares trading at 270.70p, down 1.9% on Monday’s close.

READ: MoneySupermarket.com Group sees shares slide as guidance for flat earnings in 2018 overshadows revenue growth

In a note to clients, Citi’s analysts said Moneysupermarket’s downgrade to full-year 2018 expectations and the announcement of further cost investment after completion of the prior technology replatforming “has thrown up a number of questions around near-term market share erosion and uncertainty around long-term margins.”

They added: “While we see valuation support from the 15.6x FY18e ex-cash PE, cash generative business model and net cash balance sheet, we prefer to wait on the sidelines until a clearer path to stronger profit growth emerges.”

Quick facts: Moneysupermarket.com

Price: 316.9 GBX

LSE:MONY
Market: LSE
Market Cap: £1.7 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix Health agrees exclusive deal for LPLDL in USA and Canada

Steve Prescott, the chief executive of ProBiotix, which is a wholly-owned subsidiary of OptiBiotix Health PLC (LON:OPTI), caught up for a brief chat with Proactive London's Andrew Scott after announcing they've signed a distributor agreement with Advanced NutriSolutions Inc./Select Ingredient...

8 hours, 59 minutes ago

2 min read